No enhancement of sensory and motor blockade by neostigmine added to mepivacaine axillary plexus block

Citation
H. Bouaziz et al., No enhancement of sensory and motor blockade by neostigmine added to mepivacaine axillary plexus block, ANESTHESIOL, 91(1), 1999, pp. 78-83
Citations number
22
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
ANESTHESIOLOGY
ISSN journal
00033022 → ACNP
Volume
91
Issue
1
Year of publication
1999
Pages
78 - 83
Database
ISI
SICI code
0003-3022(199907)91:1<78:NEOSAM>2.0.ZU;2-Y
Abstract
Background: Intrathecal neostigmine induces analgesia but also several side effects. Recently, 500 mu g neostigmine administered intraarticularly was shown to produce postoperative analgesia without side effects. The authors' goal was to determine whether 500 mu g neostigmine added to mepivacaine in axillary plexus block prolongs postoperative analgesia. In addition, they wanted to determine the incidence of side effects in patients undergoing ha nd surgery. Methods: Sixty-nine outpatients scheduled for car-pal tunnel syndrome repai r with axillary plexus block were randomly assigned to one of three groups that received saline solution in the axillary plexus and subcutaneously (gr oup 1), 500 mu g neostigmine in the axillary plexus and saline solution sub cutaneously (group 2), or saline solution in the axillary plexus and 500 mu g neostigmine subcutaneously (group 3). Sensory and motor block in the fou r hand nerve distributions were assessed every 5 min for 30 min. The durati on of the sensory and motor blocks were assessed after operation. Side effe cts were also recorded Results: Neostigmine had no effect on sensory and motor block in any of the four nerve distributions, nor did it increase the median duration of senso ry block (215 min; range, 120-330 min) compared with group 1 (247 min; rang e, 190-287 min) or group 3 (236 min; range, 160-280 min). Motor block was s lightly shorter (P = 0.045) in group 3 (190 min; range, 135-285 min) compar ed with group 1 (218 min; range, 145-257 min) and group 2 (215 min; range, 105-343 min). Gastrointestinal side effects occurred in 30% of patients in both neostigmine groups but not in group 1 (P < 0.05). Conclusions: This study suggests that 500 mu g neostigmine added to mepivac aine in axillary plexus block does not prolong postoperative sensory block, but it does cause a relatively high incidence of side effects. These two f indings raise doubts about the use of neostigmine associated with local ane sthetics for plexus neural block.